BLOCK HIV/HCV: Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships

Integritas Communications, in collaboration with the American Academy of HIV Medicine (AAHIVM), the American Liver Foundation (ALF), and the National Hepatitis Corrections Network (NHCN) is presenting a series of 3 live educational events across the country to improve the diagnosis and management of HIV/HCV coinfection.

AUSTIN, TEXAS (PRWEB) April 17, 2018

Integritas Communications, in collaboration with the American Academy of HIV Medicine (AAHIVM), the American Liver Foundation (ALF), and the National Hepatitis Corrections Network (NHCN) is presenting a series of 3 live educational events across the country to improve the diagnosis and management of HIV/HCV coinfection.

BLOCK HIV/HCV: Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships is designed to educate a multidisciplinary audience including community-based infectious disease specialists and other human immunodeficiency virus (HIV) treaters, gastroenterology/hepatology clinicians, mental health specialists, substance abuse specialists, correctional health care professionals, public policy/public health officials, hepatitis C virus (HCV) and HIV advocacy groups, payers, and clinical office staff who are engaged in the care of patients with HIV and/or HCV

Approximately 25% of all individuals infected with HIV are coinfected with HCV.1 Of critical significance, HIV increases the rate of progression of HCV-related hepatic fibrosis, and HCV is associated with a 3-fold increase in HIV antiretroviral therapy (ART)–induced liver toxicity.2 The BLOCK HIV/HCV initiative will provide community-based infectious disease specialists and other HIV treaters with foundational information and practical resources needed to prepare local stakeholders—both clinical and nonclinical—to collaborate in efforts to eliminate HCV within their communities.

1.    Centers for Disease Control and Prevention. HIV/AIDS and Viral Hepatitis. https://www.cdc.gov/hepatitis/populations/hiv.htm. Accessed January 24, 2018.
2.    Sulkowski MS, Benhamou Y. Therapeutic issues in HIV/HCV-coinfected patients. J Viral Hepat. 2007;14(6):371-386.

The Steering Committee for the BLOCK HIV/HCV series is comprised of Dr. David L. Wyles (Course Chair), Dr. Judith Feinberg (Charleston Co-Chair), Dr. Arthur Yu-Shin Kim (Boston Co-Chair), Dr. Lesley Miller (Atlanta Co-Chair), Dr. Susanna Naggie, and Dr. Stacey Trooskin.

After completing this activity, the participant should be better able to:

• Describe epidemiologic trends in HCV monoinfection and HIV/HCV coinfection within at-risk populations, including men who have sex with men (MSM), people who inject drugs (PWID), and incarcerated individuals
• Screen MSM, PWID, and incarcerated individuals for HCV and HIV infection
• Provide guideline-based treatment for HCV monoinfection and HIV/HCV coinfection
• Identify patient, provider, and health care system barriers to effective management of HCV monoinfection and HIV/HCV coinfection
• Implement strategies to overcome risk-cohort–specific challenges to the treatment of HCV monoinfection and HIV/HCV coinfection

Meeting Dates, Locations, and Highlights:
The meetings will be held at the following dates and locations:

• Saturday, June 2, 2018 in Charleston, WV
• Monday, September 17, 2018 in Boston, MA
• Atlanta, GA 2018 date coming soon

To register for one of these this live CME/CE programs or for any other questions, please visit http://www.blockhivhcv.com or call us at 512-708-4678.

About Integritas Communications

Integritas Communications is an independent medical education company committed to the design, development, and delivery of innovative accredited CME/CE programs for various members of the healthcare team. We focus on integrating adult learning principles and new technologies into novel educational formats that engage learners, enhance knowledge retention, and promote positive behavior change in clinical practice. As professionals dedicated to the creation of scientifically accurate, clinically relevant, and appropriately balanced CME and CE programs, members of the Integritas team have extensive experience educating clinicians in a broad range of therapeutic areas.

Release Issued by Audience Generation, LLC

Audience Generation is a forward-thinking agency at the forefront of the digital revolution and is a nationally and internationally recognized provider of integrated marketing, advertising, and technology services and solutions that offer a new way to find, generate, and engage live, online, social, and mobile audiences where they exist on demand.

Audience Generation is known for its creative strategy, actionable solutions and measurable approach to transforming the ways brands interact with their target audience, whether they exist in person, online, via social networks, or on their mobile devices.

Audience Generation has produced winning traditional, online, e-commerce, social and mobile campaigns including mobile application solutions for Fortune 500, small and medium businesses, not-for-profit organizations, national and international associations and societies, and venture-backed start-up companies across a variety of industry verticals around the world.

To learn how Audience Generation can find your ideal customer, reach them where they exist, build your brand, and grow your bottom line, please call us at 512-708-4678 or email us at mwayne@audiencegeneration.com or visit us at http://www.audiencegeneration.com.

For the original version on PRWeb visit: http://www.prweb.com/releases/2018/04/prweb15406120.htm